Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenylethylamine excretion in depression.

L E DeLisi, D L Murphy, F Karoum

    Psychiatry Research
    |November 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking.

    Nature genetics·1996
    Same author

    Working memory as assessed by subject-ordered tasks in patients with obsessive-compulsive disorder.

    Journal of clinical and experimental neuropsychology·1995
    Same author

    Long-term antidepressant treatments alter 5-HT2A and 5-HT2C receptor-mediated hyperthermia in Fawn-Hooded rats.

    European journal of pharmacology·1995
    Same author

    Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.

    Psychopharmacology·1995
    Same author

    Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively.

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·1995
    Same author

    Endoscopic knot tying made easier.

    The Australian and New Zealand journal of surgery·1995

    Depression is not linked to a general deficit in phenylethylamine (PEA). Some female patients showed high urinary PEA, but this did not correlate with phenylacetic acid (PAA) levels.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Biochemistry

    Background:

    • Phenylethylamine (PEA) is a neuromodulator implicated in mood regulation.
    • Previous research suggested potential PEA deficits in depression, but findings were inconsistent.
    • The relationship between PEA and its metabolite phenylacetic acid (PAA) in depression requires further clarification.

    Purpose of the Study:

    • To investigate urinary phenylethylamine (PEA) excretion in hospitalized patients diagnosed with depression.
    • To determine if depression is associated with a generalized PEA deficit.
    • To explore the correlation between PEA and phenylacetic acid (PAA) excretion in depressed individuals.

    Main Methods:

    • Urinary PEA levels were measured in 53 hospitalized depressed patients and 16 healthy controls.

    Related Experiment Videos

  • A subsample of 31 patients and 10 controls also had urinary PAA levels measured.
  • Statistical analysis was used to compare PEA and PAA excretion between groups and to assess correlations.

    • Main Results:

    • Seven out of 53 depressed patients exhibited urinary PEA excretion more than three times higher than controls.
    • All patients with elevated PEA excretion were female; however, they were not clinically distinct from other depressed patients.
    • No significant correlation was found between PEA and PAA excretion in the subsample analyzed.

    Conclusions:

    • The findings do not support the hypothesis of a generalized phenylethylamine (PEA) deficit in depression.
    • Elevated PEA levels in a subset of female patients suggest a more complex role for PEA in depression.
    • The lack of correlation between PEA and PAA suggests that previously reported PAA reductions may not stem from a PEA abnormality.